Donor-transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft

A Yango1, P Morrissey, R Gohh

  • 1Division of Renal Disease, Brown University School of Medicine, Rhode Island and Miriam Hospitals, 593 Eddy Street, Providence, RI 02903, USA.

Insights

Donor-transmitted parvovirus B19 infection can cause serious complications in renal transplant recipients, including pancytopenia and allograft dysfunction. Prompt treatment with intravenous immunoglobulin (Ig) leads to excellent recovery, highlighting the need for increased vigilance.

Area of Science:

  • Virology
  • Nephrology
  • Immunology

Background:

  • Parvovirus B19, a nonenveloped single-stranded DNA virus, typically causes mild childhood illness but can lead to persistent anemia and pancytopenia in immunocompromised individuals.
  • Renal involvement, including glomerulopathy and allograft dysfunction, has been increasingly reported in renal transplant recipients, often due to donor transmission.

Observation:

  • A 23-year-old male renal transplant recipient developed fever, polyarthralgia, pancytopenia, and allograft dysfunction eight weeks post-transplant.
  • Serological tests showed elevated parvovirus B19 IgM titers, and renal biopsy revealed tubular damage without rejection. Parvovirus B19 DNA was detected in renal tissue via PCR.

Findings:

  • The patient received a 10-day course of intravenous immunoglobulin (Ig) at 400 mg/kg/day.
  • Following treatment, the patient experienced normalization of blood counts and improvement in allograft function.

Implications:

  • Parvovirus B19 infection in renal transplant patients may be underdiagnosed, as symptoms can be mistaken for immunosuppressive drug side effects.
  • Active screening for parvovirus B19 is recommended in transplant patients presenting with pancytopenia and allograft dysfunction due to its treatable nature.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...